Lipomed

Switzerland Updated 9 July 2026

Lipomed is an API and finished-dose manufacturer based in Switzerland. It holds one valid CEP. Its filings concentrate with EMA, SWISSMEDIC (CH) and AIFA (IT). Its GMP standing is certified by ZLG (DE) and EMA.

active US DMFs

valid CEPs

registered plants

105

filings across 14 regulators

These figures were checked against the regulators' own files on 25 July 2026

EU GMP

1 of 1 confirmed

Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site	FDA FEI
Arlesheim, United Arab Emirates	Not on file
Arlesheim, Switzerland	Not on file
Baden-Wuerttemberg, Germany	Not on file
Weil Am Rhein, Germany	Not on file

What they file, and where

Molecule	Regulators	Docs
Cladribine	EDQM, SFDA (Saudi Arabia)	2

Also appears on these molecule pages

Azathioprine finished dose Cladribine API Dacarbazine finished dose Deferiprone finished dose Hydroxyurea finished dose

Filings and GMP by regulator

Regulator	Filings	GMP certificates
EMA	26	3
SWISSMEDIC (CH)	18	None
AIFA (IT)	12	None
ANSM (FR)	9	None
FAMHP (BE)	8	None
MPA (SE)	7	None
ZLG (DE)	None	4

Comparing suppliers?

Choose your molecules and target markets. Lipomed comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability
EudraGMDP and national regulators: GMP certificates